Goldman Sach's Hudson Street Services independent research initiative has garnered a lot of good press. Wall Street & Technology provides some interesting details on some moves by competitive firms. Credit Suisse is pushing its ResearchExchange, or Rx, which will soon nudge buy-side firms toward third-party BD and independent research. Merrill Lynch is also aiming to soon launch a new program. An interesting angle is whether these offerings are competing with their sell-side research outfits. You could argue it many ways. But I think it is clear that the idea of research is morphing into something beyond just buys, holds and sells. Increasingly, you've got to bring some higher, perhaps even tradable value.
For more:
- here's the Wall Street & Technology article